|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-1-15
|
|
pubmed:abstractText |
Radiotherapy (RT) is often the therapy of choice for patients with Stage T2 glottic carcinoma. This retrospective study updated the results of RT for patients treated at our center. The primary focus of this study was whether a policy of using hyperfractionated RT for these patients resulted in a therapeutic gain.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
322-8
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:12527044-Adult,
pubmed-meshheading:12527044-Aged,
pubmed-meshheading:12527044-Aged, 80 and over,
pubmed-meshheading:12527044-Analysis of Variance,
pubmed-meshheading:12527044-Dose Fractionation,
pubmed-meshheading:12527044-Female,
pubmed-meshheading:12527044-Glottis,
pubmed-meshheading:12527044-Humans,
pubmed-meshheading:12527044-Laryngeal Neoplasms,
pubmed-meshheading:12527044-Male,
pubmed-meshheading:12527044-Middle Aged,
pubmed-meshheading:12527044-Neoplasm Recurrence, Local,
pubmed-meshheading:12527044-Neoplasm Staging,
pubmed-meshheading:12527044-Radiation Injuries,
pubmed-meshheading:12527044-Retrospective Studies,
pubmed-meshheading:12527044-Salvage Therapy
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
|
|
pubmed:affiliation |
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. Agarden@mdanderson.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
